Recent Investment Analysts' Ratings Updates for Bristol-Myers Squibb


A number of firms have modified their ratings and price targets on shares of Bristol-Myers Squibb recently: 12/13/2018 - Bristol-Myers Squibb had its "hold" rating reaffirmed by analysts at Credit Suisse Group AG. They now have a $59.00 price target on the stock.



from Biotech News